[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Bioanalytical Testing Services Market by Type (Cell-based Assays; Virology Testing; Method Development, Optimization, and Validation; Serology, Immunogenicity, and Neutralizing Antibodies; Biomarker Testing; Pharmacokinetic Testing), Application, End User - Global Forecasts to 2025

May 2020 | 204 pages | ID: B70E66BC5275EN
MarketsandMarkets

US$ 4,950.00

E-mail Delivery (PDF)

Download PDF Leaflet

Wire Transfer
Checkout Later
Need Help? Ask a Question
“Rising focus on the analytical testing of biologics and biosimilars to drive market growth”

The global bioanalytical testing services market is projected to reach USD 3.7 billion by 2025 from USD 2.1 billion in 2020, at a CAGR of 11.8% during the forecast period. The growth in this market is attributed to the rising focus on the analytical testing of biologics and biosimilars, increasing preference for outsourcing analytical testing, growing R&D expenditure in the pharmaceutical and biopharmaceutical industries, and the rising adoption of the Quality by Design approach. However, the dearth of skilled professionals is a major factor that is expected to restrain the growth of this market during the forecast period.

“Pharmaceutical and biopharmaceutical companies were the largest end users of bioanalytical testing services in 2019”

Based on end user, the bioanalytical testing services market is segmented into pharmaceutical and biopharmaceutical companies, contract development and manufacturing organizations, and contract research organizations. In 2019, the pharmaceutical and biopharmaceutical companies segment accounted for the largest share of the bioanalytical testing services market. The large share of this segment can be attributed to the increased outsourcing of early-phase development, clinical, and laboratory testing services by pharmaceutical companies to boost profit margins, avoid high capital expenditure, and reduce the time duration to validate processes and products.

“Oncology is the largest application segment in the bioanalytical testing services market”

Based on the application area, the bioanalytical testing services market is broadly categorized into oncology, neurology, infectious diseases, gastroenterology, cardiology, and other applications. Oncology is the largest application segment in this market, primarily due to the increasing number of clinical trials conducted for oncology and the rising prevalence of cancer worldwide.

“North America will continue to dominate the bioanalytical testing services market in 2025”

The bioanalytical testing services market is segmented into North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa. In 2019, North America accounted for the largest share of the bioanalytical testing services market. The large share of North America in this market can be attributed to the high-quality standards in the pharmaceutical industry, rapid growth in the biosimilars and biologics markets, and an increase in clinical trial activity in the region.

The break-down of primary participants is as mentioned below:
  • By Company Type - Tier 1: 35%, Tier 2: 45%, and Tier 3: 20%
  • By Designation - C-level: 30%, Director-level: 55%, and Others: 15%
  • By Region - North America: 40%, Europe: 25%, Asia Pacific: 20%, Latin America: 10%, and the Middle East & Africa: 5%
The prominent players operating in the bioanalytical testing services market include Charles River (US), Medpace (US), WuXi AppTec (China), Eurofins Scientific (Luxembourg), IQVIA, Inc. (US), SGS SA (Switzerland), Laboratory Corporation of America Holdings (US), Intertek Group plc (UK), PRA Health Sciences (US), Syneos Health (US), ICON plc (Ireland), Frontage Labs (US), PPD, Inc. (US), PAREXEL International Corporation (US), Almac Group (UK), Celerion (US), Altasciences (US), BioAgilytix Labs (US), Lotus Labs Pvt. Ltd. (India), and LGS Limited (UK).

Research Coverage:

The report analyzes the bioanalytical testing services market and aims at estimating the market size and future growth potential of various market segments, based on type, application, end user, and region. The report also provides a competitive analysis of the key players operating in this market, along with their company profiles, service offerings, recent developments, and key market strategies.

Reasons to Buy the Report

This report will enrich established firms as well as new entrants/smaller firms to gauge the pulse of the market, which, in turn, would help them garner a greater share of the market. Firms purchasing the report could use one or a combination of the below-mentioned strategies to strengthen their positions in the market.

This report provides insights on:
  • Market Penetration: Comprehensive information on the product portfolios of the top players in the bioanalytical testing services market. The report analyzes this market by type, application, end user, and region
  • Market Development: Comprehensive information on the lucrative emerging markets, by type, application, end user, and region
  • Market Diversification: Exhaustive information about the service portfolios, growing geographies, recent developments, and investments in the bioanalytical testing services market
  • Competitive Assessment: In-depth assessment of market shares, growth strategies, product offerings, and capabilities of the leading players in the bioanalytical testing services market
1 INTRODUCTION

1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION & SCOPE
  1.2.1 MARKETS COVERED
  1.2.2 YEARS CONSIDERED FOR THE STUDY
1.3 CURRENCY
1.4 STAKEHOLDERS

2 RESEARCH METHODOLOGY

2.1 RESEARCH APPROACH
  2.1.1 SECONDARY DATA
    2.1.1.1 Key data from secondary sources
  2.1.2 PRIMARY DATA
    2.1.2.1 Key data from primary sources
    2.1.2.2 Key industry insights
2.2 MARKET SIZE ESTIMATION
2.3 MARKET BREAKDOWN & DATA TRIANGULATION
2.4 MARKET RANKING ANALYSIS
2.5 ASSUMPTIONS FOR THE STUDY

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

4.1 BIOANALYTICAL TESTING SERVICES MARKET OVERVIEW
4.2 ASIA PACIFIC: BIOANALYTICAL TESTING SERVICES MARKET, BY APPLICATION & COUNTRY (2019)
4.3 BIOANALYTICAL TESTING SERVICES MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
4.4 REGIONAL MIX: BIOANALYTICAL TESTING SERVICES MARKET
4.5 BIOANALYTICAL TESTING SERVICES MARKET: DEVELOPING VS.
DEVELOPED COUNTRIES

5 MARKET OVERVIEW

5.1 INTRODUCTION
5.2 MARKET DYNAMICS
  5.2.1 DRIVERS
    5.2.1.1 Rising focus on the analytical testing of biologics and biosimilars
    5.2.1.2 Increasing preference for outsourcing analytical testing
    5.2.1.3 Growing R&D expenditure in the pharmaceutical and biopharmaceutical industry
    5.2.1.4 Rising adoption of the Quality by Design approach
  5.2.2 RESTRAINTS
    5.2.2.1 Dearth of skilled professionals
    5.2.2.2 Pricing pressure faced by major players
  5.2.3 OPPORTUNITIES
    5.2.3.1 Emerging countries in the Asia Pacific region
    5.2.3.2 Rising demand for specialized bioanalytical testing services
  5.2.4 CHALLENGES
    5.2.4.1 Innovative formulations demanding a unique
bioanalytical testing approach
    5.2.4.2 Growing need to improve the sensitivity of bioanalytical methods

6 BIOANALYTICAL TESTING SERVICES MARKET, BY TYPE

6.1 INTRODUCTION
6.2 CELL-BASED ASSAYS
  6.2.1 BACTERIAL CELL-BASED ASSAYS
    6.2.1.1 Bacterial cell-based assays segment to dominate the bioanalytical testing services market for cell-based assays
  6.2.2 VIRAL CELL-BASED ASSAYS
    6.2.2.1 Increasing outbreaks of viral diseases to support the growth of this market segment
6.3 VIROLOGY TESTING
  6.3.1 IN VITRO VIROLOGY TESTING
    6.3.1.1 Higher uptake of in vitro virology assays in the development of antiviral pharmaceuticals to drive the growth of this market segment
  6.3.2 IN VIVO VIROLOGY TESTING
    6.3.2.1 High utilization of in vivo assays during important production phases to drive their demand
  6.3.3 SPECIES-SPECIFIC VIRAL PCR ASSAYS
    6.3.3.1 Wide application of species-specific viral PCR assays in the detection of viral risks to support the growth of this market segment
6.4 METHOD DEVELOPMENT OPTIMIZATION AND VALIDATION
  6.4.1 MANDATORY REQUIREMENT BY REGULATORY AUTHORITIES TO DRIVE THE GROWTH OF THIS MARKET SEGMENT
6.5 SEROLOGY, IMMUNOGENICITY, AND NEUTRALIZING ANTIBODIES
  6.5.1 INCREASING APPLICATIONS OF SEROLOGY, IMMUNOGENICITY, AND NEUTRALIZING ANTIBODIES TO DRIVE THE GROWTH OF THIS MARKET SEGMENT
  6.5.2 BACTERIAL SEROLOGY, IMMUNOGENICITY, AND NEUTRALIZING ANTIBODIES
  6.5.3 VIRAL SEROLOGY, IMMUNOGENICITY, AND NEUTRALIZING ANTIBODIES
6.6 BIOMARKER TESTING
  6.6.1 EMPHASIS ON THE DEVELOPMENT OF PERSONALIZED MEDICINE TO DRIVE THE DEMAND FOR BIOMARKER TESTING SERVICES
6.7 PHARMACOKINETIC TESTING
  6.7.1 INCREASING INCIDENCE OF INFECTIOUS DISEASES TO DRIVE THE DEMAND FOR PHARMACOKINETIC TESTING SERVICES
6.8 OTHER SERVICES

7 BIOANALYTICAL TESTING SERVICES MARKET, BY APPLICATION

7.1 INTRODUCTION
7.2 ONCOLOGY
  7.2.1 ONCOLOGY IS THE LARGEST APPLICATION SEGMENT IN THE BIOANALYTICAL TESTING SERVICES MARKET
7.3 NEUROLOGY
  7.3.1 ROBUST PIPELINE OF DRUGS FOR CNS DISEASES TO DRIVE THE GROWTH OF THIS MARKET SEGMENT
7.4 INFECTIOUS DISEASES
  7.4.1 OUTBREAK OF COVID-19 TO BOOST THE GROWTH OF THIS MARKET SEGMENT
7.5 GASTROENTEROLOGY
  7.5.1 RISING PREVALENCE OF CHRONIC DIGESTIVE DISORDERS TO SUPPORT THE GROWTH OF THIS MARKET SEGMENT
7.6 CARDIOLOGY
  7.6.1 INCREASING PREVALENCE OF CARDIOVASCULAR DISEASES TO SUPPORT THE GROWTH OF THIS MARKET SEGMENT
7.7 OTHER APPLICATIONS

8 BIOANALYTICAL TESTING SERVICES MARKET, BY END USER

8.1 INTRODUCTION
8.2 PHARMACEUTICAL AND BIOPHARMACEUTICAL COMPANIES
  8.2.1 PHARMACEUTICAL AND BIOPHARMACEUTICAL COMPANIES ARE THE LARGEST END USERS OF BIOANALYTICAL TESTING SERVICES
8.3 CONTRACT DEVELOPMENT AND MANUFACTURING ORGANIZATIONS
  8.3.1 CDMOS PROVIDE SERVICES SUCH AS ANALYTICAL DEVELOPMENT, FORMULATION SCREENING AND DEVELOPMENT, STABILITY STUDIES, AND PRE-CLINICAL SAFETY ASSESSMENT STUDIES
8.4 CONTRACT RESEARCH ORGANIZATIONS
  8.4.1 CONTRACT RESEARCH ORGANIZATIONS ARE INCREASINGLY SUBCONTRACTING THEIR ACTIVITIES TO NICHE LABORATORIES SPECIALIZED IN PROVIDING BIOANALYTICAL TESTING SERVICES

9 BIOANALYTICAL TESTING SERVICES MARKET, BY REGION

9.1 INTRODUCTION
9.2 NORTH AMERICA
  9.2.1 US
    9.2.1.1 US is the largest market for bioanalytical testing services in North America
  9.2.2 CANADA
    9.2.2.1 Increasing number of clinical trials in Canada to support market growth
9.3 EUROPE
  9.3.1 GERMANY
    9.3.1.1 Government support and flexible labor laws have made Germany a favorable location for clinical trials
  9.3.2 FRANCE
    9.3.2.1 High number of oncology clinical trials in France to drive market growth
  9.3.3 UK
    9.3.3.1 Investment by pharmaceutical sponsors in the UK for drug discovery services to support market growth
  9.3.4 ITALY
    9.3.4.1 Low drug approval time in Italy, along with the growing number of clinical trials, to drive market growth
  9.3.5 SPAIN
    9.3.5.1 Short study start-up times and rising R&D expenditure to boost the growth of the Spanish market
  9.3.6 REST OF EUROPE
9.4 ASIA PACIFIC
  9.4.1 CHINA
    9.4.1.1 China is the largest market for bioanalytical testing services in the Asia Pacific
  9.4.2 JAPAN
    9.4.2.1 Rising geriatric population to drive market growth in Japan
  9.4.3 INDIA
    9.4.3.1 Growing pharmaceutical industry in India to drive market growth
  9.4.4 REST OF ASIA PACIFIC
9.5 LATIN AMERICA
  9.5.1 GROWING R&D EXPENDITURE IN THE PHARMACEUTICAL AND BIOPHARMACEUTICAL SECTOR TO DRIVE MARKET GROWTH IN LATIN AMERICA
9.6 MIDDLE EAST & AFRICA
  9.6.1 GROWING PHARMACEUTICAL INDUSTRY TO DRIVE MARKET GROWTH IN THE MIDDLE EAST AND AFRICA

10 COMPETITIVE LANDSCAPE

10.1 INTRODUCTION
10.2 COMPETITIVE LEADERSHIP MAPPING
  10.2.1 VISIONARY LEADERS
  10.2.2 INNOVATORS
  10.2.3 DYNAMIC DIFFERENTIATORS
  10.2.4 EMERGING COMPANIES
10.3 BIOANALYTICAL TESTING SERVICES MARKET SHARE ANALYSIS
10.4 BIOANALYTICAL TESTING SERVICES MARKET: GEOGRAPHICAL ASSESSMENT
10.5 COMPETITIVE SITUATIONS & TRENDS
  10.5.1 SERVICE LAUNCHES (2017–2020)
  10.5.2 EXPANSIONS (2019–2020)
  10.5.3 AGREEMENTS, PARTNERSHIPS, AND COLLABORATIONS (2019–2020)
  10.5.4 ACQUISITIONS (2019)
  10.5.5 OTHER DEVELOPMENTS (2019)

11 COMPANY PROFILES

(Business Overview, Products Offered, Recent Developments, Strategic Overview, MnM View)*
11.1 CHARLES RIVER
11.2 MEDPACE
11.3 WUXI APPTEC
11.4 EUROFINS SCIENTIFIC
11.5 IQVIA INC.
11.6 SGS SA
11.7 LABORATORY CORPORATION OF AMERICA HOLDINGS
11.8 INTERTEK GROUP PLC
11.9 PRA HEALTH SCIENCES
11.10 SYNEOS HEALTH
11.11 ICON PLC
11.12 FRONTAGE LABS
11.13 PPD, INC.
11.14 PAREXEL INTERNATIONAL CORPORATION
11.15 ALMAC GROUP
11.16 CELERION
11.17 ALTASCIENCES
11.18 BIOAGILYTIX LABS
11.19 LOTUS LABS PVT. LTD.
11.20 LGC LIMITED
*Business Overview, Products Offered, Recent Developments, Strategic Overview, MnM View might not be captured in case of unlisted companies.

12 APPENDIX

12.1 DISCUSSION GUIDE
12.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
12.3 AVAILABLE CUSTOMIZATIONS
12.4 RELATED REPORTS
12.5 AUTHOR DETAILS

LIST OF TABLES

TABLE 1 ANNUAL AVERAGE EXCHANGE RATES USED FOR CURRENCY
CONVERSIONS TO USD
TABLE 2 PATENT EXPIRY OF BEST-SELLING BIOLOGICS
TABLE 3 BIOANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 4 BIOANALYTICAL TESTING SERVICES MARKET FOR CELL-BASED ASSAYS, BY TYPE, 2018–2025 (USD MILLION)
TABLE 5 BIOANALYTICAL TESTING SERVICES MARKET FOR CELL-BASED ASSAYS, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 6 BIOANALYTICAL TESTING SERVICES MARKET FOR BACTERIAL CELL-BASED ASSAYS, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 7 BIOANALYTICAL TESTING SERVICES MARKET FOR VIRAL CELL-BASED ASSAYS, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 8 BIOANALYTICAL TESTING SERVICES MARKET FOR VIROLOGY TESTING, BY TYPE, 2018–2025 (USD MILLION)
TABLE 9 BIOANALYTICAL TESTING SERVICES MARKET FOR VIROLOGY TESTING, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 10 BIOANALYTICAL TESTING SERVICES MARKET FOR IN VITRO VIROLOGY TESTING, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 11 BIOANALYTICAL TESTING SERVICES MARKET FOR IN VIVO VIROLOGY TESTING, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 12 BIOANALYTICAL TESTING SERVICES MARKET FOR SPECIES-SPECIFIC VIRAL PCR ASSAYS, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 13 BIOANALYTICAL TESTING SERVICES MARKET FOR METHOD DEVELOPMENT OPTIMIZATION AND VALIDATION, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 14 BIOANALYTICAL TESTING SERVICES MARKET FOR SEROLOGY, IMMUNOGENICITY, AND NEUTRALIZING ANTIBODIES, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 15 BIOANALYTICAL TESTING SERVICES MARKET FOR BACTERIAL SEROLOGY, IMMUNOGENICITY, AND NEUTRALIZING ANTIBODIES, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 16 BIOANALYTICAL TESTING SERVICES MARKET FOR VIRAL SEROLOGY, IMMUNOGENICITY, AND NEUTRALIZING ANTIBODIES, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 17 BIOANALYTICAL TESTING SERVICES MARKET FOR BIOMARKER TESTING, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 18 BIOANALYTICAL TESTING SERVICES MARKET FOR PHARMACOKINETIC TESTING, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 19 BIOANALYTICAL TESTING SERVICES MARKET FOR OTHER SERVICES, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 20 BIOANALYTICAL TESTING SERVICES MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 21 BIOANALYTICAL TESTING SERVICES MARKET FOR ONCOLOGY, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 22 LIST OF PIPELINE DRUGS FOR NEUROLOGICAL DISORDERS (2018)
TABLE 23 BIOANALYTICAL TESTING SERVICES MARKET FOR NEUROLOGY, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 24 BIOANALYTICAL TESTING SERVICES MARKET FOR INFECTIOUS DISEASES, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 25 BIOANALYTICAL TESTING SERVICES MARKET FOR GASTROENTEROLOGY, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 26 LIST OF PIPELINE DRUGS FOR CARDIOVASCULAR DISEASES (2018)
TABLE 27 BIOANALYTICAL TESTING SERVICES MARKET FOR CARDIOLOGY, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 28 BIOANALYTICAL TESTING SERVICES MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 29 BIOANALYTICAL TESTING SERVICES MARKET, BY END USER, 2018–2025 (USD MILLION)
TABLE 30 BIOANALYTICAL TESTING SERVICES MARKET FOR PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 31 BIOANALYTICAL TESTING SERVICES MARKET FOR CONTRACT DEVELOPMENT AND MANUFACTURING ORGANIZATIONS, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 32 BIOANALYTICAL TESTING SERVICES MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 33 BIOANALYTICAL TESTING SERVICES MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 34 NORTH AMERICA: BIOANALYTICAL TESTING SERVICES MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 35 NORTH AMERICA: BIOANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 36 NORTH AMERICA: CELL-BASED ASSAYS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 37 NORTH AMERICA: VIROLOGY TESTING MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 38 NORTH AMERICA: SEROLOGY, IMMUNOGENICITY, AND NEUTRALIZING ANTIBODIES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 39 NORTH AMERICA: BIOANALYTICAL TESTING SERVICES MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 40 NORTH AMERICA: BIOANALYTICAL TESTING SERVICES MARKET, BY END USER, 2018–2025 (USD MILLION)
TABLE 41 KEY INDICATORS: US
TABLE 42 US: BIOANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 43 US: CELL-BASED ASSAYS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 44 US: VIROLOGY TESTING MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 45 US: BIOANALYTICAL TESTING SERVICES MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 46 US: BIOANALYTICAL TESTING SERVICES MARKET, BY END USER, 2018–2025 (USD MILLION)
TABLE 47 KEY INDICATORS: CANADA
TABLE 48 NUMBER OF ACTIVE CLINICAL TRIALS IN CANADA, BY CONDITION (2019)
TABLE 49 CANADA: BIOANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 50 CANADA: CELL-BASED ASSAYS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 51 CANADA: VIROLOGY TESTING MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 52 CANADA: BIOANALYTICAL TESTING SERVICES MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 53 CANADA: BIOANALYTICAL TESTING SERVICES MARKET, BY END USER, 2018–2025 (USD MILLION)
TABLE 54 EUROPE: BIOANALYTICAL TESTING SERVICES MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 55 EUROPE: BIOANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 56 EUROPE: CELL-BASED ASSAYS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 57 EUROPE: VIROLOGY TESTING MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 58 EUROPE: BIOANALYTICAL TESTING SERVICES MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 59 EUROPE: BIOANALYTICAL TESTING SERVICES MARKET, BY END USER, 2018–2025 (USD MILLION)
TABLE 60 KEY INDICATORS: GERMANY
TABLE 61 GERMANY: BIOANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 62 GERMANY: CELL-BASED ASSAYS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 63 GERMANY: VIROLOGY TESTING MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 64 GERMANY: BIOANALYTICAL TESTING SERVICES MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 65 GERMANY: BIOANALYTICAL TESTING SERVICES MARKET, BY END USER, 2018–2025 (USD MILLION)
TABLE 66 KEY INDICATORS: FRANCE
TABLE 67 FRANCE: BIOANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 68 FRANCE: CELL-BASED ASSAYS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 69 FRANCE: VIROLOGY TESTING MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 70 FRANCE: BIOANALYTICAL TESTING SERVICES MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 71 FRANCE: BIOANALYTICAL TESTING SERVICES MARKET, BY END USER, 2018–2025 (USD MILLION)
TABLE 72 KEY INDICATORS: UK
TABLE 73 UK: BIOANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 74 UK: CELL-BASED ASSAYS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 75 UK: VIROLOGY TESTING MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 76 UK: BIOANALYTICAL TESTING SERVICES MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 77 UK: BIOANALYTICAL TESTING SERVICES MARKET, BY END USER, 2018–2025 (USD MILLION)
TABLE 78 KEY INDICATORS: ITALY
TABLE 79 ITALY: BIOANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 80 ITALY: CELL-BASED ASSAYS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 81 ITALY: VIROLOGY TESTING MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 82 ITALY: BIOANALYTICAL TESTING SERVICES MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 83 ITALY: BIOANALYTICAL TESTING SERVICES MARKET, BY END USER, 2018–2025 (USD MILLION)
TABLE 84 KEY INDICATORS: SPAIN
TABLE 85 SPAIN: BIOANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 86 SPAIN: CELL-BASED ASSAYS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 87 SPAIN: VIROLOGY TESTING MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 88 SPAIN: BIOANALYTICAL TESTING SERVICES MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 89 SPAIN: BIOANALYTICAL TESTING SERVICES MARKET, BY END USER, 2018–2025 (USD MILLION)
TABLE 90 ROE: BIOANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 91 ROE: CELL-BASED ASSAYS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 92 ROE: VIROLOGY TESTING MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 93 ROE: BIOANALYTICAL TESTING SERVICES MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 94 ROE: BIOANALYTICAL TESTING SERVICES MARKET, BY END USER, 2018–2025 (USD MILLION)
TABLE 95 ASIA PACIFIC: BIOANALYTICAL TESTING SERVICES MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 96 ASIA PACIFIC: BIOANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 97 ASIA PACIFIC: CELL-BASED ASSAYS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 98 ASIA PACIFIC: VIROLOGY TESTING MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 99 ASIA PACIFIC: BIOANALYTICAL TESTING SERVICES MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 100 ASIA PACIFIC: BIOANALYTICAL TESTING SERVICES MARKET, BY END USER, 2018–2025 (USD MILLION)
TABLE 101 KEY INDICATORS: CHINA
TABLE 102 CHINA: BIOANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 103 CHINA: CELL-BASED ASSAYS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 104 CHINA: VIROLOGY TESTING MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 105 CHINA: BIOANALYTICAL TESTING SERVICES MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 106 CHINA: BIOANALYTICAL TESTING SERVICES MARKET, BY END USER, 2018–2025 (USD MILLION)
TABLE 107 KEY INDICATORS: JAPAN
TABLE 108 JAPAN: BIOANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 109 JAPAN: CELL-BASED ASSAYS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 110 JAPAN: VIROLOGY TESTING MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 111 JAPAN: BIOANALYTICAL TESTING SERVICES MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 112 JAPAN: BIOANALYTICAL TESTING SERVICES MARKET, BY END USER, 2018–2025 (USD MILLION)
TABLE 113 INCREASE IN THE R&D EXPENDITURE OF THE TOP 5 INDIAN PHARMACEUTICAL COMPANIES (2010 VS. 2018)
TABLE 114 KEY INDICATORS: INDIA
TABLE 115 INDIA: BIOANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 116 INDIA: CELL-BASED ASSAYS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 117 INDIA: VIROLOGY TESTING MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 118 INDIA: BIOANALYTICAL TESTING SERVICES MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 119 INDIA: BIOANALYTICAL TESTING SERVICES MARKET, BY END USER, 2018–2025 (USD MILLION)
TABLE 120 ROAPAC: BIOANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 121 ROAPAC: CELL-BASED ASSAYS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 122 ROAPAC: VIROLOGY TESTING MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 123 ROAPAC: BIOANALYTICAL TESTING SERVICES MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 124 ROAPAC: BIOANALYTICAL TESTING SERVICES MARKET, BY END USER, 2018–2025 (USD MILLION)
TABLE 125 NUMBER OF CLINICAL TRIALS IN LATINA AMERICA, BY COUNTRY (JUNE 2019)
TABLE 126 LATIN AMERICA: BIOANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 127 LATIN AMERICA: CELL-BASED ASSAYS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 128 LATIN AMERICA: VIROLOGY TESTING MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 129 LATIN AMERICA: BIOANALYTICAL TESTING SERVICES MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 130 LATIN AMERICA: BIOANALYTICAL TESTING SERVICES MARKET, BY END USER, 2018–2025 (USD MILLION)
TABLE 131 MIDDLE EAST & AFRICA: BIOANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 132 MIDDLE EAST & AFRICA: CELL-BASED ASSAYS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 133 MIDDLE EAST & AFRICA: VIROLOGY TESTING MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 134 MIDDLE EAST & AFRICA: BIOANALYTICAL TESTING SERVICES MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 135 MIDDLE EAST & AFRICA: BIOANALYTICAL TESTING SERVICES MARKET, BY END USER, 2018–2025 (USD MILLION)

LIST OF FIGURES

FIGURE 1 BIOANALYTICAL TESTING SERVICES MARKET SEGMENTATION
FIGURE 2 RESEARCH DESIGN
FIGURE 3 PRIMARY SOURCES
FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
FIGURE 5 MARKET SIZE ESTIMATION: SUPPLY-SIDE ANALYSIS
FIGURE 6 DATA TRIANGULATION METHODOLOGY
FIGURE 7 BIOANALYTICAL TESTING SERVICES MARKET, BY TYPE, 2020 VS. 2025 (USD MILLION)
FIGURE 8 BIOANALYTICAL TESTING SERVICES MARKET, BY APPLICATION, 2020 VS. 2025 (USD MILLION)
FIGURE 9 BIOANALYTICAL TESTING SERVICES MARKET, BY END USER, 2020 VS. 2025 (USD MILLION)
FIGURE 10 BIOANALYTICAL TESTING SERVICES MARKET: REGIONAL SNAPSHOT
FIGURE 11 RISING FOCUS ON THE ANALYTICAL TESTING OF BIOLOGICS AND BIOSIMILARS TO DRIVE MARKET GROWTH
FIGURE 12 ONCOLOGY SEGMENT ACCOUNTED FOR THE LARGEST SHARE OF THE APAC BIOANALYTICAL TESTING SERVICES MARKET IN 2019
FIGURE 13 CHINA TO REGISTER THE HIGHEST GROWTH DURING THE FORECAST PERIOD
FIGURE 14 NORTH AMERICA WILL CONTINUE TO DOMINATE THE BIOANALYTICAL TESTING SERVICES MARKET DURING THE FORECAST PERIOD
FIGURE 15 DEVELOPING COUNTRIES TO REGISTER HIGHER GROWTH DURING THE FORECAST PERIOD
FIGURE 16 BIOANALYTICAL TESTING SERVICES MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
FIGURE 17 PHARMACEUTICAL & BIOPHARMACEUTICAL R&D EXPENDITURE, 2017–2024
FIGURE 18 NUMBER OF REGISTERED STUDIES, 2001–2019
FIGURE 19 NUMBER OF PIPELINE DRUGS, BY COMPANY, 2019
FIGURE 20 GLOBAL NUMBER OF CLINICAL TRIALS IN DIFFERENT THERAPEUTIC AREAS, 2015–2018
FIGURE 21 WORLDWIDE CANCER INCIDENCE AND MORTALITY (2018–2040)
FIGURE 22 ANNUAL DRUG APPROVALS BY CDER (2010–2019)
FIGURE 23 PHARMACEUTICAL R&D SPENDING, 2010–2018
FIGURE 24 ACTIVE PHARMACEUTICAL PIPELINE, 2001–2019
FIGURE 25 CHINA IS EXPECTED TO WITNESS THE HIGHEST GROWTH DURING
THE FORECAST PERIOD
FIGURE 26 TOTAL NUMBER OF CLINICAL TRIALS: GLOBAL VS. NORTH AMERICA (2019)
FIGURE 27 NORTH AMERICA: BIOANALYTICAL TESTING SERVICES MARKET SNAPSHOT
FIGURE 28 US: PIPELINE SPLIT OF PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY PHASE (JANUARY 2019)
FIGURE 29 TOTAL R&D EXPENDITURE OF THE US PHARMACEUTICAL INDUSTRY (2010–2018)
FIGURE 30 EUROPE: BIOANALYTICAL TESTING SERVICES MARKET SNAPSHOT
FIGURE 31 UK: PHARMACEUTICAL R&D EXPENDITURE, 2013–2017 (USD BILLION)
FIGURE 32 UK: COMMERCIAL CLINICAL TRIAL APPLICATIONS, BY PHASE, 2013–2017
FIGURE 33 ASIA PACIFIC: BIOANALYTICAL TESTING SERVICES MARKET SNAPSHOT
FIGURE 34 KEY DEVELOPMENTS IN THE BIOANALYTICAL TESTING SERVICES MARKET
FIGURE 35 BIOANALYTICAL TESTING SERVICES MARKET (GLOBAL) COMPETITIVE LEADERSHIP MAPPING, 2019
FIGURE 36 MARKET SHARE ANALYSIS: BIOANALYTICAL TESTING SERVICES MARKET (2019)
FIGURE 37 GEOGRAPHIC ASSESSMENT OF KEY PLAYERS IN THE BIOANALYTICAL TESTING SERVICES MARKET (2018)
FIGURE 38 CHARLES RIVER: COMPANY SNAPSHOT (2019)
FIGURE 39 MEDPACE: COMPANY SNAPSHOT (2018)
FIGURE 40 WUXI APPTEC: COMPANY SNAPSHOT (2018)
FIGURE 41 EUROFINS SCIENTIFIC: COMPANY SNAPSHOT (2019)
FIGURE 42 IQVIA INC.: COMPANY SNAPSHOT (2019)
FIGURE 43 SGS SA: COMPANY SNAPSHOT (2019)
FIGURE 44 LABORATORY CORPORATION OF AMERICA HOLDINGS:
COMPANY SNAPSHOT (2019)
FIGURE 45 INTERTEK GROUP PLC: COMPANY SNAPSHOT (2019)
FIGURE 46 PRA HEALTH SCIENCES: COMPANY SNAPSHOT (2019)
FIGURE 47 SYNEOS HEALTH: COMPANY SNAPSHOT (2019)
FIGURE 48 ICON PLC: COMPANY SNAPSHOT (2019)
FIGURE 49 FRONTAGE LABS: COMPANY SNAPSHOT (2018)


More Publications